Chaoju Eye Care Holdings Limited, together with its subsidiaries, owns and operates a network of ophthalmic hospitals and centers in the People's Republic of China. The company offers in-patient and out-patient ophthalmic medical services; and consumer ophthalmic services, including treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, and myopia prevention and control. It also provides basic ophthalmic services for the treatment of a range of eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases, dry eye syndrome, and oculoplastic and pediatric eye diseases. In addition, the company engages in investment management activities; and the sale of equipment, optical products, and medical consumables. Chaoju Eye Care Holdings Limited was founded in 1988 and is headquartered in Beijing, China.
Frequently asked questions
What sector does Chaoju Eye Care Holdings Ltd (2219) operate in?
Chaoju Eye Care Holdings Ltd belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is Chaoju Eye Care Holdings Ltd (2219) current stock price?
As of the latest data, Chaoju Eye Care Holdings Ltd stock price is HK$2.52, with a previous close of HK$2.55. Chaoju Eye Care Holdings Ltd lost -HK$0.03 in the last trading session, representing a -0.98% loss.
What is Chaoju Eye Care Holdings Ltd (2219) current market capitalization?
Chaoju Eye Care Holdings Ltd market cap is approximately 1.74 billion.
Does Chaoju Eye Care Holdings Ltd (2219) pay dividends?
Yes. Chaoju Eye Care Holdings Ltd pays annual dividends with an annualized yield of 9.62% and an estimated annual payout of HK$0.24 per share.
When is the next ex-dividend date for Chaoju Eye Care Holdings Ltd (2219)?
The next ex-dividend date is scheduled for May 14, 2027.
What is Chaoju Eye Care Holdings Ltd (2219) beta (volatility) score?
Chaoju Eye Care Holdings Ltd has a beta of 0.581, indicating lower volatility than the overall market.
